Keytruda Shows Promise in People with Advanced Disease, Early Phase 2 Trial Results Show
News
Merck’s Keytruda (pembrolizumab) shows promise as a treatment for advanced, previously treated cervical squamous cell cancer, according to a preliminary analysis of a Phase 2 trial. The data, which will ... Read more